Clinical trial
Tivozanib + Enzalutamide in Adv Prostate Cancer
NCT01885949
Study timeline
Study start (actual)2013-09-03Date precision: day
Registry last updated2026-05-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
TivozanibDRUG · verified · RxNorm: tivozanib
EnzalutamideDRUG · verified · RxNorm: enzalutamide
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
National Comprehensive Cancer Networkcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01885949 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.